Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD34 cell separation: from basic research to clinical applications

G Nadali1, E A de Wynter, N G Testa

  • 1CRC Department of Experimental Haematology, Paterson Institute for Cancer Research, Manchester, UK.

International Journal of Clinical & Laboratory Research
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia.

Blood cell therapy·2024
Same author

Fungal infections of the central nervous system and paranasal sinuses in onco-haematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases.

Mycoses·2018
Same author

Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.

Annals of hematology·2018
Same author

Haemopoietic growth factors: their role in cell development and their clinical use.

Cytotechnology·2012
Same author

Mesenchymal stem cells from CD34(-) human umbilical cord blood.

Transfusion medicine (Oxford, England)·2009
Same author

What is the future for cord blood stem cells?

Cytotechnology·2008
Same journal

Lack of association of fibrinogen, lipoprotein(a), and albumin excretion rate with low birthweight.

International journal of clinical & laboratory research·2001
Same journal

Assay of erythrocyte membrane fatty acids. Effects of storage time at low temperature.

International journal of clinical & laboratory research·2001
Same journal

Bovine seminal RNase induces apoptosis in normal proliferating lymphocytes.

International journal of clinical & laboratory research·2001
Same journal

Cigarette smoking as an aggravating factor in inflammatory tissue-destructive diseases. Increase in tumor necrosis Factor-alpha priming of peripheral neutrophils measured as generation of oxygen radicals.

International journal of clinical & laboratory research·2001
Same journal

Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.

International journal of clinical & laboratory research·2001
Same journal

Antigastric autoantibodies in Helicobacter pylori infection: role in gastric mucosal inflammation.

International journal of clinical & laboratory research·2001
See all related articles

Immunological identification advances enable CD34+ cell purification for clinical applications. Ongoing research focuses on mobilizing, characterizing, and transplanting these primitive hematopoietic stem cells.

Area of Science:

  • Hematology
  • Immunology
  • Cell Biology

Background:

  • Advances in immunological identification of primitive hematopoietic cells.
  • Expression of the CD34 antigen is key for stem cell characterization and purification.

Purpose of the Study:

  • Review different CD34 purification systems.
  • Discuss applications in research and clinical settings.
  • Report clinical outcomes and future prospects of CD34+ cell selection.

Main Methods:

  • Review of CD34 purification systems.
  • Analysis of clinical results from CD34+ cell selection.

Main Results:

  • Large-scale CD34+ cell isolation systems are used clinically.

Related Experiment Videos

  • CD34 purification systems have diverse research applications.
  • Clinical results of CD34+ selection are reported.

    • Conclusions:

    • CD34+ cell purification technologies are advancing for clinical use.
    • Continued research aims to optimize mobilization, characterization, purification, and transplantation.
    • The technology holds significant future potential in clinical practice.